Healthcare entity
All 1 tracked stories fall under one category: regulation. Clostridium botulinum is most often covered alongside CDC, which appears in 1 of these 1 story. The tracked stories average 2 original sources each. Clostridium botulinum appears in 1 tracked Healthcare story from June 15, 2026.
Last mentioned: Jun 15, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: regulation. Clostridium botulinum is most often covered alongside CDC, which appears in 1 of these 1 story. The tracked stories average 2 original sources each. Clostridium botulinum appears in 1 tracked Healthcare story from June 15, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 7 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Clostridium botulinum. Shared-story counts are live from our verified record — not editorial picks.
Three infants in three states were diagnosed with botulism after consuming Nara Organics powdered formula, prompting a voluntary recall of all whole milk formula. All babies recovered, but the FDA and CDC investigation highlights risks of powdered formula for newborns and emphasizes clinical vigilance among pediatricians.
Clostridium botulinum is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
